Treatment–Refractory Schizophrenia

Treatment–Refractory Schizophrenia

Author: Peter F. Buckley

Publisher: Springer Science & Business Media

Published: 2014-03-18

Total Pages: 231

ISBN-13: 3642452574

DOWNLOAD EBOOK

Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care. In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.


First Episode Psychosis

First Episode Psychosis

Author: Katherine J. Aitchison

Publisher: CRC Press

Published: 1999-02-17

Total Pages: 152

ISBN-13: 9781853174353

DOWNLOAD EBOOK

The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management.


Polypharmacy in Psychiatry

Polypharmacy in Psychiatry

Author: S. Nassir Ghaemi

Publisher: CRC Press

Published: 2002-05-06

Total Pages: 363

ISBN-13: 020390902X

DOWNLOAD EBOOK

This practical reference examines the advantages and disadvantages of polypharmacy in psychiatry, and provides up-to-date clinical guidelines on the appropriate use of combinations of pharmacological therapy in major psychiatric disorders-including multidisciplinary approaches to treatment, such as social work and psychopharmacology, and an examina


The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia

The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia

Author: American Psychiatric Association

Publisher: American Psychiatric Pub

Published: 2016

Total Pages: 220

ISBN-13: 0890426775

DOWNLOAD EBOOK

The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms.


Dyskinesia

Dyskinesia

Author: D.E. Casey

Publisher: Springer Science & Business Media

Published: 2013-03-12

Total Pages: 368

ISBN-13: 364270140X

DOWNLOAD EBOOK

Papers Presented at an International Symposium, Held in 1984 at Kollekolle, Denmark


Drug Induced Movement Disorders

Drug Induced Movement Disorders

Author: Stewart Factor

Publisher: John Wiley & Sons

Published: 2008-04-15

Total Pages: 480

ISBN-13: 140513755X

DOWNLOAD EBOOK

The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.


Antipsychotic Long-acting Injections

Antipsychotic Long-acting Injections

Author: Peter Haddad

Publisher: Oxford University Press

Published: 2016-05-10

Total Pages: 266

ISBN-13: 0191045780

DOWNLOAD EBOOK

Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use in the United States and is likely to be approved in Europe soon. The second edition of this successful book has been fully updated to include this new data, with reference to both observational studies and randomized controlled trials, as well as other new developments in the clinical use of antipsychotic LAIs. New chapters have been added covering the comparison between oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and the practicalities of organizing a specialized clinic for long-acting injectable antipsychotics. Existing chapters have also been thoroughly updated to take into account the most recently published research. Antipsychotic Long-acting Injections, Second edition brings together clinical and research findings on LAIs in a comprehensive volume, with chapters written by international experts.